HTuO Biosciences

Achira

This company develops atomistic simulation software combining physics and machine learning to enable drug discovery for biotechnology and pharmaceutical organisations.

Deep Origin

This company provides a computational drug discovery platform for biopharmaceutical researchers to simulate molecular properties and accelerate therapeutic development.

Valence Discovery

This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.

Inductive Bio

This company provides a machine learning platform for compound optimization and ADMET prediction to biopharma and drug discovery organisations.

Avicenna Biosciences

The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.

Freecurve

This company develops molecular simulation software for researchers in drug discovery and materials science to predict the physical behaviour of complex systems.

POTENTIAL SCIENCES

Potential Sciences develops GPU-native quantum chemistry simulation software for molecular modelling, serving customers in the pharmaceutical and biotechnology sectors.

Aqemia

This company develops a drug discovery platform using physics-based algorithms and artificial intelligence for pharmaceutical and biotechnology organisations.